Saudi Arabia Cardiac Resynchronization Therapy Market valued at $82 Mn in 2022, projected to reach $135 Mn by 2030 with a 6.5% CAGR. The increasing worldwide incidence of heart failure, propelled by aging demographics and cardiovascular diseases linked to lifestyle, emerges as a significant factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, prominent players in this market encompass Medtronic, Abbott, Boston Scientific, Johnson & Johnson, Biotronik, St. Jude Medical, LivaNova, MicroPort, Sorin Group, and Siemens Healthineers.
The Saudi Arabia Physiotherapy Equipment Market was valued at $355.30 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $637.09 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are HMS Medical Systems, Fitness Equipment, Medexsol, and Medical Elements Co. among others.
The Saudi Arabia Patient Adherence Programs Market was valued at $220.3 Mn in 2023 and is predicted to grow at a CAGR of 19.5% from 2023 to 2030, to $766.5 Mn by 2030. The key drivers of the market include. The prominent players of the Saudi Arabia Patient Adherence Programs Market are Jamjoom Pharmaceuticals, Tabuk Pharmaceuticals, AstraZeneca, Jazeera Pharmaceutical Industries, and Sitco Pharma, among others.
The Saudi Arabia Dental Consumables Market was valued at $574.6 Mn in 2023 and is projected to grow at a CAGR of 9.5% from 2023 to 2023, to $1084.6 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, and changing living standards. The industry is primarily dominated by players such as Dentsply Sirona, Henry Schein, GC Corporation, Septodent, Osstem Implant, 3M among others.
Saudi Arabia LASIK Surgery Market was valued at $60.01 Mn in 2023 and is predicted to grow at a CAGR of 6.71% from 2023 to 2030, to $94.55 Mn by 2030. The key drivers of this industry include rising prevalence, growing disposable income, and government initiatives. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
The Saudi Arabia Biosensors Market was valued at $491.3 Mn in 2023 and is predicted to grow at a CAGR of 9.5% from 2023 to 2030, to $927.4 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, emphasis on preventative care, and aging population. The prominent players of the Saudi Arabia Biosensors Market are Jamjoom Medical Industries, Annahdah Medical Company, Al-Ewan Medical Company, Almafsal Medical Company, and Al Razi Medical Company, among others.
Saudi Arabia Hemodialysis Vascular Grafts Market was valued at $3.56 Bn in 2023 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $5.57 Bn by 2030. The key drivers of this industry include the rising prevalence of end-stage renal disease, the growing geriatric population, and government initiatives and investment in healthcare. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
Saudi Arabia Breastfeeding Accessories Market was valued at $42.67 Mn in 2023 and is predicted to grow at a CAGR of 8.30% from 2023 to 2030, to $74.56 Mn by 2030. The key drivers of this industry include high breastfeeding initiation rates, increasing urbanization and maternal employment, and health recommendations. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
The Saudi Arabia Hospital Market was valued at $93.49 Bn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $172.01 Bn by 2030. The key drivers of this industry are burden of chronic diseases, government investments, and focus on preventive care. The key players in the industry are Dr. Sulaiman Al Habib Medical Group, Saudi German Hospitals Group, Elaj Group, and Kingdom Hospital among others.
The Saudi Arabia Hemodialysis Equipment Market was valued at $240 Mn in 2023 and is projected to grow at a CAGR of 9.1% from 2023 to 2023, to $441.6 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Siemens Healthineers, Boston Scientific Corporation, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd, Nipro Corp among others.
The Saudi Arabia Central Nervous System (CNS)Therapeutics Market was valued at $3.570 Bn in 2022 and is predicted to grow at a CAGR of 7.9% from 2023 to 2030, to $6.559 Bn by 2030. The key drivers of this industry include the rising burden of CNS diseases, expanding healthcare spending, and technological advancements in the industry. The industry is primarily dominated by players such as Pfizer, Novartis, Hikma Pharmaceutical, Otsuka, AbbVie, and Eli Lilly among others.